Liquidia to Present at the 2020 Jefferies Virtual London Healthcare Conference

Rhea-AI Summary

Liquidia Technologies (Nasdaq: LQDA) announced that CEO Neal Fowler will present at the 2020 Jefferies Virtual London Healthcare Conference on November 19, 2020, at 7:55 PM GMT. The presentation will be available via a live audio webcast, with a replay accessible for at least 90 days. Liquidia is focused on developing innovative products using its proprietary PRINT® technology, particularly two candidates: LIQ861 for pulmonary arterial hypertension and LIQ865 for post-operative pain relief.

RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, today announced that Neal Fowler, Chief Executive Officer of Liquidia, will present at the 2020 Jefferies Virtual London Healthcare Conference at 7:55 PM GMT (2:55 PM ET) on Thursday, November 19, 2020.

A link to the live audio webcast and replay of the presentation will be available on the Events & Presentations page of the Company’s corporate website, and will be archived for a minimum of 90 days.

About Liquidia

Liquidia is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC. For more information, please visit www.liquidia.com.

Contact Information

Investor Relations:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com

FAQ

When is Neal Fowler's presentation at the Jefferies Virtual London Healthcare Conference?

Neal Fowler's presentation at the Jefferies Virtual London Healthcare Conference is scheduled for November 19, 2020, at 7:55 PM GMT.

What is Liquidia Technologies focusing on in their product development?

Liquidia Technologies is focusing on developing LIQ861 for pulmonary arterial hypertension and LIQ865 for local post-operative pain.

How can I access Neal Fowler's presentation after the event?

The presentation will be available via a live audio webcast and can be replayed for a minimum of 90 days.

What technology does Liquidia Technologies utilize for its products?

Liquidia Technologies utilizes its proprietary PRINT® technology for the development of its novel products.

What stock symbol represents Liquidia Technologies?

Liquidia Technologies is represented by the stock symbol LQDA.